Letter: Effect of levodopa on tremor in Benedikt's syndrome

Fujieda, T; Yamauchi, T; Takahashi, S; Moroji, T
March 1974
British Medical Journal;3/9/1974, Vol. 1 Issue 5905, p456
Academic Journal
No abstract available.


Related Articles

  • Benedikt's syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p255 

    An encyclopedia entry for "Benedikt's syndrome," which is characterized by hemiplegia with oculomotor paralysis and clonic tremor, is presented.

  • Benedikt's syndrome.  // Taber's Cyclopedic Medical Dictionary;2005, p238 

    A definition of the medical term "Benedikt's syndrome" is presented. Benedikt's syndrome is a hemiplegia with oculomotor paralysis and clonic spasm or tremor on the opposite side. It is caused by lesions that damage the third nerve and involve the red nucleus and corticospinal tract.

  • SHORT REPORTS. Briet, E.; Vismans, F.J.; van Voorthuisen, A.E.; Oswald, Ian; Adam, Kirstine; Barrison, I.G.; Viola, L.; Murray-Lyon, Iain M.; Jenkins, J.; Sainsbury, P.; van de Wiel, A.; Flinterman, J.; Kerckhaert, J.A.M.; Boeff, J.A.Du; Imhof, J.W.; Bydder, G.M.; Chapman, R.W.G.; Findley, L.J. // British Medical Journal;10/18/1980, Vol. 281 Issue 6247, p1039 

    Reports developments related to medicine. Effects of Benzodiazepine on weight; Preference on the use of bupivacaine on intravenous regional analgesia; Action of levodopa on the suppression of tremor.

  • CITATIONS AND CLINICIANS' NOTES: MOVEMENT DISORDERS.  // Current Medical Literature: Neurology;2004, Vol. 20 Issue 3, p62 

    Discusses abstracts of articles concerning movement disorders, compiled as of September 2004. "Treatment of Idiopathic Restless Legs Syndrome (RLS) with Slow-Release Valproic Acid Compared With Slow-Release Levodopa/Benserazid," by I. Eisensehr and colleagues; "Ropinirole for Restless Legs...

  • Levodopa: back to the future. Zappia, Mario; Colosimo, Carlo; Poewe, Werner // Journal of Neurology;Nov2010, Vol. 257, p247 

    An introduction to the journal is presented in which the editor discusses the importance of levodopa in the pharmacology of Parkinson's disease, the side-effects of levodopa such as dopamine dysregulation syndrome (DSS), and the development of new drug formulations of levodopa.

  • Pallido-pyramidal syndrome with blepharospasm and good response to levodopa. Srivastava, Trilochan; Goyal, Vinay; Singh, Sumit; Shukla, Garima; Behari, Madhuri // Journal of Neurology;Dec2005, Vol. 252 Issue 12, p1537 

    The article presents a letter to the editor that provides information about pallido-pyramidal syndrome with blepharospasm and good response to levodopa.

  • Literature Review: MEDICAL TREATMENT.  // Current Medical Literature: Parkinson's Disease;2003, Vol. 5 Issue 2, p43 

    Evaluates the medical treatment for Parkinson's disease (PD). Improvement in the quality of life among PD patients with the introduction of levodopa; Effectiveness of apomorphine therapy; Tremor suppression effect of pramipexole compared to dopamine agonists.

  • Methodological considerations in determining the effects of films with suicidal content. Jha, Shailesh; Kumar, Rajesh // British Journal of Psychiatry;Dec2015, Vol. 207 Issue 6, p562 

    A letter to the editor is presented in response to the article "Determining the effects of films with suicidal content: A laboratory experiment" by Benedikt Till and colleagues in a 2015 issue.

  • Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). McDowell, Fletcher; Lee, John E.; Swift, Thomas; Sweet, Richard D.; Ogsbury, James S.; Kessler, Jeffrey T.; McDowell, F; Lee, J E; Swift, T; Sweet, R D; Ogsbury, J S; Kessler, J T // Annals of Internal Medicine;Jan70, Vol. 72 Issue 1, p29 

    In 1967 Cotzias recommended d, i, dihydroxy-phenylalanine (levodopa) for the treatment of Parkinson's syndrome. Since then 100 patients have been treated at Cornell University Medical College for a minimum of 6 months. Sixty percent of the patients showed 50% or more improvement, in some...

  • Levodopa/carbidopa/entacapone.  // Reactions Weekly;2/14/2009, Issue 1239, p20 

    The article describes the case of a man with Parkinson's disease who developed acute Pisa syndrome after switching from levodopa benserazide to levodopa/carbidopa/entacapone. He was diagnosed with Parkinson's disease and started treatment one year later with levodopa/benserazide. He had rest and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics